Liraglutide Dosage Guide
FDA Approved
Written by Alejandro Reyes
Founder & Lead Researcher
PN
Reviewed by Peptide Nerds Editorial · Updated April 2026
Not medical advice. Dosage information is provided for educational purposes based on published research.
Always consult a qualified healthcare provider before starting any protocol. Full disclaimer.
Dosage overview
| Typical dose | 3.0 mg daily |
| Frequency | Once daily subcutaneous injection |
Dosing notes
Titrate from 0.6 mg daily, increasing by 0.6 mg weekly.
FDA-approved indications
Liraglutide is FDA-approved for: Type 2 diabetes (Victoza), weight management (Saxenda).
Off-label use should only be pursued under the guidance of a licensed healthcare provider.
Important safety information
Dosage ranges listed above are based on published clinical trial protocols. Individual dosing should be determined by a qualified healthcare provider based on your specific health profile, goals, and response to treatment.
- Start at the lowest effective dose and titrate up gradually
- Monitor for side effects, especially during dose increases
- Do not exceed researched dose ranges without medical supervision
Research references
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE) — New England Journal of Medicine (2015) [PubMed]
Free Peptide Weight Loss Guide
Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.